These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8088010)

  • 1. Elevated serum and urinary thrombomodulin levels in patients with non-insulin-dependent diabetes mellitus.
    Shimano H; Takahashi K; Kawakami M; Gotoda T; Harada K; Shimada M; Yazaki Y; Yamada N
    Clin Chim Acta; 1994 Mar; 225(2):89-96. PubMed ID: 8088010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of elevation of serum and urinary concentrations of soluble thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury.
    Aso Y; Inukai T; Takemura Y
    Metabolism; 1998 Mar; 47(3):362-5. PubMed ID: 9500578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease.
    Hirano T; Ookubo K; Kashiwazaki K; Tajima H; Yoshino G; Adachi M
    Clin Chim Acta; 2000 Sep; 299(1-2):65-75. PubMed ID: 10900293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.
    Fawzy MS; Abu AlSel BT
    J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study.
    Morcos M; Borcea V; Isermann B; Gehrke S; Ehret T; Henkels M; Schiekofer S; Hofmann M; Amiral J; Tritschler H; Ziegler R; Wahl P; Nawroth PP
    Diabetes Res Clin Pract; 2001 Jun; 52(3):175-83. PubMed ID: 11323087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
    Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY; Chen FQ
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal handling of glycated albumin in non-insulin-dependent diabetes mellitus with nephropathy.
    Cha T; Tahara Y; Yamato E; Yoneda H; Ikegami H; Noma Y; Shima K; Ogihara T
    Diabetes Res Clin Pract; 1991 Jul; 12(3):149-56. PubMed ID: 1889345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus.
    Borcea V; Morcos M; Isermann B; Henkels M; Ziegler S; Zumbach M; Amiral J; Längst KD; Seiz W; Ziegler R; Wahl P; Nawroth PP
    Vasa; 1999 Aug; 28(3):172-80. PubMed ID: 10483322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated urinary D-lactate levels in patients with diabetes and microalbuminuria.
    Chou CK; Lee YT; Chen SM; Hsieh CW; Huang TC; Li YC; Lee JA
    J Pharm Biomed Anal; 2015 Dec; 116():65-70. PubMed ID: 26166004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus.
    Clemens A; Klevesath MS; Hofmann M; Raulf F; Henkels M; Amiral J; Seibel MJ; Zimmermann J; Ziegler R; Wahl P; Nawroth PP
    Metabolism; 1999 Oct; 48(10):1236-40. PubMed ID: 10535384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of measurements of urinary and serum thrombomodulins in patients with non-insulin-dependent diabetes mellitus.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Takemura Y
    Diabetes Res Clin Pract; 1996 Jul; 33(2):99-104. PubMed ID: 8879964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.